Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne A Gershon

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Current Topics in Microbiology and Immunology|March 13, 2010
VZV infection of keratinocytes: production of cell-free infectious virions in vivoMichael D Gershon, Anne A Gershon
Current Topics in Microbiology and Immunology|March 17, 2010
Perspectives on vaccines against varicella-zoster virus infectionsAnne A Gershon, Michael D Gershon
Mbio|December 5, 2022
Varicella Vaccine: a Molecular Variant That May Contribute to AttenuationAnne A Gershon, Michael D Gershon
The Journal of Infectious Diseases|May 3, 2008
Perspective on live varicella vaccineAnne A Gershon, Samuel L Katz
Clinical Microbiology Reviews|October 5, 2013
Pathogenesis and current approaches to control of varicella-zoster virus infectionsAnne A Gershon, Michael D Gershon
The Journal of Infectious Diseases|October 20, 2022
Clinical Manifestations of Varicella: Disease Is Largely Forgotten, but It's Not GoneKathleen Dooling, Mona Marin, Anne A Gershon
Viruses|November 8, 2018
Clinical Features of Varicella-Zoster Virus InfectionPeter G E Kennedy, Anne A Gershon
Pediatrics|September 1, 2019
Transmission of Vaccine-Strain Varicella-Zoster Virus: A Systematic ReviewMona Marin, Jessica Leung, Anne A Gershon
The Journal of Infectious Diseases|May 3, 2008
A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neuronsAnne A Gershon, Jason Chen, Michael D Gershon
The Journal of Infectious Diseases|May 3, 2008
Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicellaJudith Breuer, D Scott Schmid, Anne A Gershon
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Current Topics in Microbiology and Immunology|March 13, 2010
VZV infection of keratinocytes: production of cell-free infectious virions in vivoMichael D Gershon, Anne A Gershon
Current Topics in Microbiology and Immunology|March 17, 2010
Perspectives on vaccines against varicella-zoster virus infectionsAnne A Gershon, Michael D Gershon
Mbio|December 5, 2022
Varicella Vaccine: a Molecular Variant That May Contribute to AttenuationAnne A Gershon, Michael D Gershon
The Journal of Infectious Diseases|May 3, 2008
Perspective on live varicella vaccineAnne A Gershon, Samuel L Katz
Clinical Microbiology Reviews|October 5, 2013
Pathogenesis and current approaches to control of varicella-zoster virus infectionsAnne A Gershon, Michael D Gershon
The Journal of Infectious Diseases|October 20, 2022
Clinical Manifestations of Varicella: Disease Is Largely Forgotten, but It's Not GoneKathleen Dooling, Mona Marin, Anne A Gershon
Viruses|November 8, 2018
Clinical Features of Varicella-Zoster Virus InfectionPeter G E Kennedy, Anne A Gershon
Pediatrics|September 1, 2019
Transmission of Vaccine-Strain Varicella-Zoster Virus: A Systematic ReviewMona Marin, Jessica Leung, Anne A Gershon
The Journal of Infectious Diseases|May 3, 2008
A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neuronsAnne A Gershon, Jason Chen, Michael D Gershon
The Journal of Infectious Diseases|May 3, 2008
Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicellaJudith Breuer, D Scott Schmid, Anne A Gershon
Pageof 7